Latest news
Bezos and Gates Back ‘Fungi-Derived’ Drugmaker LifeMine in $263M Raise - WowtaleWowtale · Fri, 07 Aug 2026 21:05:30 GMTLifeMine gets $263m for transplant drug, and other financings - pharmaphorumpharmaphorum · Fri, 07 Aug 2026 08:56:56 GMTLifeMine Therapeutics Raises $263M in Watertown, MA - HoodlineHoodline · Thu, 06 Aug 2026 18:42:10 GMTWith $263M, LifeMine unearths a new drug for organ transplants - BioPharma DiveBioPharma Dive · Thu, 06 Aug 2026 13:40:35 GMTLifeMine CEO Verdine Raises $263M From Bezos and Gates to Replace Tacrolimus, the Transplant Drug That Destroys Kidneys - finance.biggo.comfinance.biggo.com · Thu, 06 Aug 2026 13:09:00 GMT‘Greg, you’ve got to bring back this platform’: How LifeMine won over Gates and Bezos for $188M series E - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 10:30:00 GMTGreg Verdine’s LifeMine raises $263M for safer immunosuppressant - Endpoints NewsEndpoints News · Thu, 06 Aug 2026 10:30:00 GMT